John Langenfeld
Director, Thoracic Oncology Program · Rutgers Health
Credentials: · · ·
History
- Present
- 1987–1993
University Hospital
- 1983–1987
Research
Clinical Cancer Research · 1997 · 353 citations
Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors
Molecular Cancer Research · 2004 · 226 citations
Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism
Proceedings of the National Academy of Sciences of the United States of America · 1997 · First of 5 authors · 171 citations
14 papers
- JA
9 papers
- ED
7 papers
- JM
6 papers · 1 as a fellow
6 papers · 3 as a resident
6 papers
5 papers · 5 as a resident
- DA
4 papers
Grants
- 2018–2024
Developing Bone Morphogenetic Receptor II Inhibitors for the Treatment of Cancer
National Cancer Institute · R01
Contact PI · $3.2M · Rbhs -Cancer Institute of New Jersey
- 2002–2005
The Role of a Bone Morphogenetic Protein in Lung Cancer
National Cancer Institute · K22
Contact PI · $470.6K · Univ of Med/Dent Nj-r w Johnson Med Sch